Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
CALL
Corbus Pharmaceuticals
CRBP
$166M
| $1.75M | ﹤0.01% |
+85,000
| New | +$4.35M |
|
2902
Pennant Group
PNTG
$1.4B
| $1.75M | ﹤0.01% |
49,101
+38,763
| +375% | +$1.19M |
|
2903
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.07B
| $1.75M | ﹤0.01% |
17,900
-17,400
| -49% | -$1.67M |
|
2904
Mativ Holdings
MATV
$481M
| $1.75M | ﹤0.01% |
102,836
+71,436
| +228% | +$1.25M |
|
2905
NuScale Power
SMR
$2.91B
| $1.75M | ﹤0.01% |
150,791
+124,441
| +472% | +$1.27M |
|
2906
John B. Sanfilippo & Son
JBSS
$967M
| $1.74M | ﹤0.01% |
18,471
+14,675
| +387% | +$1.42M |
|
2907
DoubleLine Fortune 500 Equal Weight ETF
DFVE
$35.1M
| $1.74M | ﹤0.01% |
60,000
| – | – |
|
|
SAVE
2908
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.74M | ﹤0.01% |
+725,300
| New | +$2M |
|
2909
Replimune Group
REPL
$941M
| $1.74M | ﹤0.01% |
158,491
+98,791
| +165% | +$1M |
|
2910
Comstock Resources
CRK
$3.89B
| $1.73M | ﹤0.01% |
155,614
+111,934
| +256% | +$1.15M |
|
|
INFA
2911
DELISTED
Informatica
INFA
| $1.73M | ﹤0.01% |
68,462
-23,774
| -26% | -$603K |
|
2912
Central Pacific Financial
CPF
$1.02B
| $1.73M | ﹤0.01% |
58,493
+26,755
| +84% | +$688K |
|
2913
Oaktree Specialty Lending
OCSL
$1.02B
| $1.73M | ﹤0.01% |
105,766
+2,140
| +2% | +$36.6K |
|
2914
Dutch Bros
BROS
$9.03B
| $1.72M | ﹤0.01% |
53,750
-95,868
| -64% | -$3.38M |
|
2915
iShares MSCI China ETF
MCHI
$6.29B
| $1.72M | ﹤0.01% |
33,790
-9,576
| -22% | -$406K |
|
2916
Washington Trust Bancorp
WASH
$743M
| $1.72M | ﹤0.01% |
53,315
+16,511
| +45% | +$505K |
|
2917
Coastal Financial
CCB
$626M
| $1.72M | ﹤0.01% |
31,804
+11,922
| +60% | +$598K |
|
2918
Miller Industries
MLR
$573M
| $1.72M | ﹤0.01% |
28,131
+15,082
| +116% | +$907K |
|
2919
Ironwood Pharmaceuticals
IRWD
$696M
| $1.72M | ﹤0.01% |
416,320
+219,304
| +111% | +$1.18M |
|
2920
POSCO
PKX
$16.1B
| $1.71M | ﹤0.01% |
24,393
-4,000
| -14% | -$261K |
|
2921
Neumora Therapeutics
NMRA
$298M
| $1.71M | ﹤0.01% |
129,210
+100,678
| +353% | +$1.17M |
|
2922
Horizon Bancorp
HBNC
$1.04B
| $1.7M | ﹤0.01% |
109,553
+42,218
| +63% | +$629K |
|
2923
Atour Lifestyle Holdings
ATAT
$4.67B
| $1.7M | ﹤0.01% |
65,587
-70,061
| -52% | -$1.3M |
|
2924
Orion
OEC
$381M
| $1.7M | ﹤0.01% |
95,512
+72,793
| +320% | +$1.4M |
|
2925
Worthington Steel
WS
$1.83B
| $1.7M | ﹤0.01% |
50,010
+38,043
| +318% | +$1.31M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.